LY300503 structure
|
Common Name | LY300503 | ||
|---|---|---|---|---|
| CAS Number | 148905-79-7 | Molecular Weight | 249.74 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H16ClNO | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LY300503LY300503 is an enantiomer of LY191704. LY191704 is a human type I 5α-reductase inhibitor[1][2]. |
| Name | LY300503 |
|---|
| Description | LY300503 is an enantiomer of LY191704. LY191704 is a human type I 5α-reductase inhibitor[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | LY300503 (30-300 mg/kg; p.o. for 14 d) exhibits the mean dose-normalized AUC value of 56% after the first dose and 38% after the last dose in rats[2]. |
| References |
| Molecular Formula | C14H16ClNO |
|---|---|
| Molecular Weight | 249.74 |